Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | -16.67% | -16.67% | -28.57% |
04-29 | Alterity Therapeutics Limited Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Diseases | CI |
04-16 | ADRs End Lower, Purple Biotech Ltd. Declines 29% | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.57% | 17.34M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ATH Stock
- News Alterity Therapeutics Limited
- Alterity Therapeutics Begins Dosing for Phase 2 Multiple System Atrophy Trial